La investigació es realitza parcialment en les instal·lacions del Laboratori de Recerca Translacional de l’Institut Català d’Oncologia (ICO) -Bellvitge Institut de Recerca Biomèdica (IDIBELL) en virtut d’un acord marc entre ambdues entitats.
La investigació es realitza parcialment en les instal·lacions del Laboratori de Recerca Translacional de l’Institut Català d’Oncologia (ICO) -Bellvitge Institut de Recerca Biomèdica (IDIBELL) en virtut d’un acord marc entre ambdues entitats.
SANCHO PARDO, GEMMA FGS
gsancho@santpau.cat
Balart Serra, Josep FGS
Cifuentes Antolinez, Patricia IR
Farre Bernado, Nuria FGS
Isern Verdum, Josep FGS
Julia Sanahuja, Joan Carles FGS
Majercakova , Katarina FGS
Mera Errasti, Maria Arantzazu FGS
Montezuma Niño, Laura Constanza FGS
Rojas Cordero, Jady Vivian FGS
Soto Cambres, Ana Maria FGS
Vila Capel, Antoni FGS
(JIF 2023)
-Bonet M, Gonzalez D, Baquedano JE, Garcia E, Altabas M, Casas F, Feltes N, Ferrer F, Foro P, Fuentes R, Galdeano M, Gomez D, Henriquez I, Jove J, Lozano J, Maldonado X, Mases J, Membrive I, Paredes S, Rosello A, Sancho G, Mira M. Management of high-risk and post-operative non-metastatic prostate cancer in Catalonia: an expert Delphi consensus. Clinical & Translational Oncology. 2023; 25(4). DOI:10.1007/s12094-022-03005-4. PMID:36436177. IF:2,800 (Q2/5D). Document type: Article.
-León X, Farré N, Montezuma L, Holgado A, Vásquez R, Neumann E, Quer M. Results of radiotherapy in oropharyngeal carcinomas. Acta Otorrinolaringologica Espanola. 2023; 74(3). DOI:10.1016/j.otorri.2022.04.002. PMID:37149134. IF:0,900 (Q3/8D). Document type: Article.
-Lococo F, Boldrini L, Diepriye CD, Evangelista J, Nero C, Flamini S, Minucci A, De Paolis E, Vita E, Cesario A, Annunziata S, Calcagni ML, Chiappetta M, Cancellieri A, Larici AR, Cicchetti G, Troost E, Róza Á, Farré N, Ozturk E, Van D, Leoncini F, Urbani A, Trisolini R, Bria E, Giordano A, Rindi G, Sala E, Tortora G, Valentini V, Boccia S, Margaritora S, Scambia G. Lung cancer multi-omics digital human avatars for integrating precision medicine into clinical practice: the LANTERN study. BMC CANCER. 2023; 23(1):540. DOI:10.1186/s12885-023-10997-x. PMID:37312079. IF:3,400 (Q2/4D). Document type: Article.
-Moreno P, Gamboa O, Gonzalez C, Romero A, Serra JB, Diaz GD, Malaver G, Bouleftour W, Magne N. hTERT and IGF-1R Proteins Expression in Response to Treatment in Patients with HPV Alpha 9-Positive Cervical Cancer. RADIATION RESEARCH. 2023; 199(5). DOI:10.1667/RADE-22-00121.1. PMID:36888727. IF:2,500 (Q2/4D). Document type: Article.
-Oladeru OT, Dunn SA, Li J, Coles CE, Yamauchi C, Chang JS, Cheng SHC, Kaidar O, Meattini I, Ramiah D, Kirby A, Hijal T, Marta GN, Poortmans P, Isern J, Zissiadis Y, Offersen BV, Refaat T, Elsayad K, Hijazi H, Dengina N, Belkacemi Y, Luo FD, Lu S, Griffin C, Collins M, Ryan P, Larios D, Warren LE, Punglia RS, Wong JS, Spiegel DY, Jagsi R, Taghian A, Bellon JR, Ho AY. Looking Back: International Practice Patterns in Breast Radiation Oncology From a Case-Based Survey Across 54 Countries During the First Surge of the COVID-19 Pandemic. Jco Global Oncology. 2023; 9:e2300010. DOI:10.1200/GO.23.00010. PMID:37471670. IF:3,200 (Q2/5D). Document type: Article.
-Pérez-Fidalgo JA, Ortega E, Ponce J, Redondo A, Sevilla I, Valverde C, Isern Verdum J, de Alava E, Galera López M, Marquina G, Sebio A. Uterine sarcomas: clinical practice guidelines for diagnosis, treatment, and follow-up, by Spanish group for research on sarcomas (GEIS). Ther Adv Med Oncol. 2023; 15:17588359231157645. DOI: 10.1177/17588359231157645. PMID: 37007636. IF:4,300 (Q2/3D). Document type: Review.
-Redondo S, Garcia I, Vila A, Esquirol A, Portos JM, Novelli S, Saavedra S, Moreno C, Garrido A, Arguello M, Onate G, Lopez J, Caballero AC, Miqueleiz S, Briones J, Sierra J, Sancho G, Martino R. Sequence matters: Total body irradiation (TBI)-based myeloablative conditioning with post-transplant cyclophosphamide may reduce the early nonrelapse mortality compared with pretransplant cyclophosphamide plus TBI. EUROPEAN JOURNAL OF HAEMATOLOGY. 2023; 111(1). DOI:10.1111/ejh.13978. PMID:37058419. IF:2,300 (Q2/5D). Document type: Article.
(JIF 2022)